DEF: Vivani Medical, Inc. Announces 2025 Annual Meeting of Stockholders and Proxy Statement

Vivani Medical, Inc. invites stockholders to its 2025 Annual Meeting on June 24, 2025, to vote on director elections, auditor ratification, and executive compensation.

Summary

• Vivani Medical, Inc. has announced its 2025 Annual Meeting of Stockholders to be held virtually on June 24, 2025.
• Stockholders will vote on the election of six directors, ratification of BPM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and a non-binding advisory vote on executive compensation.
• The record date for determining stockholders eligible to vote is April 25, 2024.
• The proxy statement and 2024 Annual Report are available online at www.proxydocs.com/VANI.
• The board of directors recommends voting FOR all proposals.

Sentiment

Score: 6

Explanation: The document is neutral in tone, providing factual information about the upcoming annual meeting and proposals. The mention of net losses and delinquent filings slightly lowers the sentiment.

Positives

• The company is providing stockholders with multiple avenues to participate in the Annual Meeting, including online access and voting.
• The board is actively seeking stockholder input on executive compensation through a non-binding advisory vote.
• The company has adopted a Compensation Recovery Policy to recover incentive-based compensation from executive officers in the event of an accounting restatement.

Negatives

• The company reported net losses of $23,486,000 in 2024, $25,652,000 in 2023, and $13,889,000 in 2022.
• There were two instances of delinquent Section 16(a) reports filed by Donald Dwyer and Gregg Williams due to administrative error.

Risks

• The company's future success depends on its ability to attract and retain qualified personnel.
• The company's stock price may be volatile and subject to market fluctuations.
• The company faces risks associated with financial reporting, tax, accounting, disclosure, internal control over financial reporting, financial policies, investment guidelines, cybersecurity and credit and liquidity matters.

Future Outlook

The company is focused on attracting and retaining talented executives and aligning compensation with stockholder interests.

Management Comments

• Adam Mendelsohn, Chief Executive Officer, invites stockholders to attend the Annual Meeting and emphasizes the importance of their vote.
• The Board encourages stockholders to read the proxy statement thoroughly and vote on the matters to be decided at the Annual Meeting.

Industry Context

The document reflects standard corporate governance practices for publicly traded companies, including proxy solicitations, director elections, and executive compensation disclosures.

Comparison to Industry Standards

• The director compensation structure, including cash retainers and equity awards, is consistent with industry practices for publicly traded companies of similar size and stage.
• The use of a compensation consultant (Compensia, LLC) to assess director, executive, and employee compensation is a common practice among publicly traded companies.
• The adoption of a Compensation Recovery Policy (clawback policy) is in line with Nasdaq listing rules and reflects a commitment to good corporate governance.

Related Party Transactions

• Private sale transaction with Gregg Williams: Vivani sold 3,968,253 shares of Common Stock to Mr. Williams at $1.26 per share.
• Share purchase agreement with Gregg Williams: Vivani entered into an agreement for the purchase of 7,366,071 shares at $1.12 per share.

Stakeholder Impact

• Stockholders have the opportunity to influence the company's direction through voting on key proposals.
• Executive compensation decisions impact the alignment of management's interests with those of stockholders.
• The selection of an independent auditor ensures the integrity of the company's financial reporting.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold the Annual Meeting on June 24, 2025, and announce the voting results.
• The company will continue to implement its compensation policies and corporate governance practices.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Executive Compensation, Auditor, Governance, Voting, Vivani Medical